Vulnerability in Oracle Life Sciences Inform
CVE-2026-34323
Vulnerability in the Oracle Life Sciences InForm product of Oracle Life Science Applications (component: IDM Authentication). Supported versions that are affected are 7.0.1.0 and 7.0.1.1. Easily exploitable vulnerability allows unauthenticated attacker with network access via HTTP to compromise Oracle Life Sciences InForm. Successful attacks require human interaction from a person other than the attacker. Successful attacks of this vulnerability can result in unauthorized update, insert or delete access to some of Oracle Life Sciences InForm accessible data as well as unauthorized read access to a subset of Oracle Life Sciences InForm accessible data and unauthorized ability to cause a partial denial of service (partial DOS) of Oracle Life Sciences InForm. CVSS 3.1 Base Score 6.3 (Confidentiality, Integrity and Availability impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L).
Published · last modified .
CVSS v3 metric
CVSS v3 base score 6.3 (Medium). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:U/C:L/I:L/A:L.
EPSS exploit prediction
EPSS: 0.002 (13.8th percentile), scored .
Very low probability of exploitation in the next 30 days; routine patching cadence is appropriate. 14th percentile — 13.8% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.
EPSS over last 30 days · oldest: 0.002 · newest: 0.002 · change: +0.001
Affected products
- Oracle Life Sciences Inform — versions 7.0.1.0, 7.0.1.1
- Oracle Corporation Life Sciences Inform — versions 7.0.1.0, 7.0.1.1
Weakness classification (CWE)
References
- www.oracle.com/security-alerts/cpuapr2026.html (vendor-advisory, Vendor Advisory)
Frequently asked questions
- What is CVE-2026-34323?
- CVE-2026-34323 is a medium-severity vulnerability in Oracle Life Sciences Inform, classified under Improper Access Control. CVSS score: 6.3/10. Published 2026-04-21.
- How severe is CVE-2026-34323?
- Medium severity. CVSS v3 base score is 6.3 out of 10.